{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:31:50Z","timestamp":1760131910115},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s11912-007-0034-z","type":"journal-article","created":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T03:51:09Z","timestamp":1184644269000},"page":"278-284","source":"Crossref","is-referenced-by-count":19,"title":["Cancer-related constipation"],"prefix":"10.1007","volume":"9","author":[{"given":"Jay","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,12]]},"reference":[{"key":"34_CR1","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"G.F. Longstreth","year":"2006","unstructured":"Longstreth GF, Thompson WG, Chey WD, et al.: Functional bowel disorders. Gastroenterology 2006, 130:1480\u20131491.","journal-title":"Gastroenterology"},{"issue":"Suppl1","key":"34_CR2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1572-0241.2005.50613_2.x","volume":"100","author":"L.J. Brandt","year":"2005","unstructured":"Brandt LJ, Prather CM, Quigley EM, et al.: Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 2005, 100(Suppl 1):S5\u2013S21.","journal-title":"Am J Gastroenterol"},{"key":"34_CR3","first-page":"213","volume":"4","author":"N.P. Sykes","year":"2006","unstructured":"Sykes NP: The pathogenesis of constipation. J Support Oncol 2006, 4:213\u2013218.","journal-title":"J Support Oncol"},{"key":"34_CR4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1191\/026921698674125048","volume":"12","author":"N.P. Sykes","year":"1998","unstructured":"Sykes NP: The relationship between opioid use and lax ative use in terminally ill cancer patients. Palliat Med 1998, 12:375\u2013382.","journal-title":"Palliat Med"},{"key":"34_CR5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000213852","volume":"43","author":"O.A. Gomes","year":"1997","unstructured":"Gomes OA, de Souza RR, Liberti EA: A preliminary investigation of the effects of aging on the nerve cell number in the myenteric ganglia of the human colon. Gerontology 1997, 43:210\u2013217.","journal-title":"Gerontology"},{"key":"34_CR6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0033-3182(90)72196-2","volume":"31","author":"M. Garvey","year":"1990","unstructured":"Garvey M, Noyes R, Jr., Yates W: Frequency of constipation in major depression: relationship to other clinical variables. Psychosomatics 1990, 31:204\u2013206.","journal-title":"Psychosomatics"},{"key":"34_CR7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1742-1241.1986.tb07949.x","volume":"40","author":"G.C. Fenn","year":"1986","unstructured":"Fenn GC, Wilkinson PD, Lee CE, Akbar FA: A general practice study of the efficacy of Regulan in functional constipation. Br J Clin Pract 1986, 40:192\u2013197.","journal-title":"Br J Clin Pract"},{"key":"34_CR8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2036.1995.tb00433.x","volume":"9","author":"W. Ashraf","year":"1995","unstructured":"Ashraf W, Park F, Lof J, Quigley EM: Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Aliment Pharmacol Ther 1995, 9:639\u2013647.","journal-title":"Aliment Pharmacol Ther"},{"key":"34_CR9","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/gut.26.10.1008","volume":"26","author":"K.J. Moriarty","year":"1985","unstructured":"Moriarty KJ, Kelly MJ, Beetham R, Clark ML: Studies on the mechanism of action of dioctyl sodium sulphosuccinate in the human jejunum. Gut 1985, 26:1008\u20131013.","journal-title":"Gut"},{"key":"34_CR10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0885-3924(96)00011-5","volume":"11","author":"N.P. Sykes","year":"1996","unstructured":"Sykes NP: A volunteer model for the comparison of laxatives in opioid-related constipation. J Pain Symptom Manage 1996, 11:363\u2013369.","journal-title":"J Pain Symptom Manage"},{"key":"34_CR11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1532-5415.1978.tb01967.x","volume":"26","author":"J.F. Sanders","year":"1978","unstructured":"Sanders JF: Lactulose syrup assessed in a double-blind study of elderly constipated patients. J Am Geriatr Soc 1978, 26:236\u2013239.","journal-title":"J Am Geriatr Soc"},{"key":"34_CR12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/gut.9.1.84","volume":"9","author":"A. Wesselius-De Casparis","year":"1968","unstructured":"Wesselius-De Casparis A, Braadbaart S, et al.: Treatment of chronic constipation with lactulose syrup: results of a double-blind study. Gut 1968, 9:84\u201386.","journal-title":"Gut"},{"key":"34_CR13","first-page":"261","volume":"85","author":"R.I. Andorsky","year":"1990","unstructured":"Andorsky RI, Goldner F: Colonic lavage solution (polyethylene glycol electrolyte lavage solution) as a treatment for chronic constipation: a double-blind, placebo-controlled study. Am J Gastroenterol 1990, 85:261\u2013265.","journal-title":"Am J Gastroenterol"},{"key":"34_CR14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1572-0241.2000.01765.x","volume":"95","author":"J.A. DiPalma","year":"2000","unstructured":"DiPalma JA, DeRidder PH, Orlando RC, et al.: A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 2000, 95:446\u2013450.","journal-title":"Am J Gastroenterol"},{"key":"34_CR15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/000992280204100405","volume":"41","author":"D.A. Gremse","year":"2002","unstructured":"Gremse DA, Hixon J, Crutchfield A: Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children. Clin Pediatr (Phila) 2002, 41:225\u2013229.","journal-title":"Clin Pediatr (Phila)"},{"key":"34_CR16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/BF02087539","volume":"39","author":"E.E. Soffer","year":"1994","unstructured":"Soffer EE, Metcalf A, Launspach J: Misoprostol is effective treatment for patients with severe chronic constipation. Dig Dis Sci 1994, 39:929\u2013933.","journal-title":"Dig Dis Sci"},{"key":"34_CR17","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1046\/j.1365-2036.1997.00237.x","volume":"11","author":"T.P. Roarty","year":"1997","unstructured":"Roarty TP, Weber F, Soykan I, McCallum RW: Misoprostol in the treatment of chronic refractory constipation: results of a long-term open label trial. Aliment Pharmacol Ther 1997, 11:1059\u20131066.","journal-title":"Aliment Pharmacol Ther"},{"key":"34_CR18","first-page":"1112","volume":"98","author":"G.N. Verne","year":"2003","unstructured":"Verne GN, Davis RH, Robinson ME, et al.: Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterol 2003, 98:1112\u20131116.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl1","key":"34_CR19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000139860","volume":"47","author":"A. Lyden-Sokolowski","year":"1993","unstructured":"Lyden-Sokolowski A, Nilsson A, Sjoberg P: Two-year carcinogenicity study with sennosides in the rat: emphasis on gastro-intestinal alterations. Pharmacology 1993, 47Suppl 1:209\u2013215.","journal-title":"Pharmacology"},{"key":"34_CR20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00204-005-0021-9","volume":"80","author":"J.M. Mitchell","year":"2006","unstructured":"Mitchell JM, Mengs U, McPherson S, et al.: An oral carcinogenicity and toxicity study of senna (Tinnevelly senna fruits) in the rat. Arch Toxicol 2006, 80:34\u201344.","journal-title":"Arch Toxicol"},{"key":"34_CR21","first-page":"A298","volume":"126","author":"R. Ueno","year":"2004","unstructured":"Ueno R, Osama H, Habe T, et al.: Oral SPI-0211 increases intestinal fluid secretion and chloride concentration without altering serum electrolyte levels Gastroenterology 2004, 126:A298 (abstract M1109).","journal-title":"Gastroenterology"},{"key":"34_CR22","doi-asserted-by":"crossref","first-page":"G942","DOI":"10.1152\/ajpgi.00264.2005","volume":"290","author":"M. Camilleri","year":"2006","unstructured":"Camilleri M, Bharucha AE, Ueno R, et al.: Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 2006, 290:G942\u2013G947.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"34_CR23","doi-asserted-by":"crossref","first-page":"s328","DOI":"10.14309\/00000434-200509001-00896","volume":"100","author":"J. Johanson","year":"2005","unstructured":"Johanson J, Gargano M, Holland P, et al.: Phase III study of lubiprostone, a chloride channel-2 (ClC-2) activator for the treatment of constipation: safety and primary efficacy [abstract]. Am J Gastroenterol 2005, 100:s328\u2013s329.","journal-title":"Am J Gastroenterol"},{"key":"34_CR24","doi-asserted-by":"crossref","first-page":"A48","DOI":"10.1016\/S0016-5085(03)80235-4","volume":"124","author":"J. Johanson","year":"2003","unstructured":"Johanson J, Gargano M, Holland P, et al.: Phase III efficacy and safety of RU-0211, a novel chloride channel activator, for the treatment of constipation Gastroenterology 2003, 124:A48.","journal-title":"Gastroenterology"},{"key":"34_CR25","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1542-3565(04)00356-8","volume":"2","author":"J.F. Johanson","year":"2004","unstructured":"Johanson JF, Wald A, Tougas G, et al.: Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol 2004, 2:796\u2013805.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"34_CR26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1572-0241.2005.40749.x","volume":"100","author":"M.A. Kamm","year":"2005","unstructured":"Kamm MA, Muller-Lissner S, Talley NJ, et al.: Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol 2005, 100:362\u2013372.","journal-title":"Am J Gastroenterol"},{"key":"34_CR27","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1046\/j.1365-2036.2001.01094.x","volume":"15","author":"S.A. Muller-Lissner","year":"2001","unstructured":"Muller-Lissner SA, Fumagalli I, Bardhan KD, et al.: Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001, 15:1655\u20131666.","journal-title":"Aliment Pharmacol Ther"},{"key":"34_CR28","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1046\/j.1365-2036.2002.01372.x","volume":"16","author":"J. Novick","year":"2002","unstructured":"Novick J, Miner P, Krause R, et al.: A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002, 16:1877\u20131888.","journal-title":"Aliment Pharmacol Ther"},{"key":"34_CR29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.52.5.671","volume":"52","author":"J. Kellow","year":"2003","unstructured":"Kellow J, Lee OY, Chang FY, et al.: An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 2003, 52:671\u2013676.","journal-title":"Gut"},{"key":"34_CR30","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1542-3565(05)00434-9","volume":"3","author":"J. Gonenne","year":"2005","unstructured":"Gonenne J, Camilleri M, Ferber I, et al.: Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study. Clin Gastroenterol Hepatol 2005, 3:784\u2013791.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"34_CR31","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/0091270004273491","volume":"45","author":"C.S. Yuan","year":"2005","unstructured":"Yuan CS, Doshan H, Charney MR, et al.: Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans. J Clin Pharmacol 2005, 45:538\u2013546.","journal-title":"J Clin Pharmacol"},{"key":"34_CR32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpain.2004.12.001","volume":"6","author":"D.M. Paulson","year":"2005","unstructured":"Paulson DM, Kennedy DT, Donovick RA, et al.: Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction\u2014a 21-day treatment-randomized clinical trial. J Pain 2005, 6:184\u2013192.","journal-title":"J Pain"},{"key":"34_CR33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.283.3.367","volume":"283","author":"C.S. Yuan","year":"2000","unstructured":"Yuan CS, Foss JF, O\u2019Connor M, et al.: Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial. JAMA 2000, 283:367\u2013372.","journal-title":"JAMA"},{"issue":"16S","key":"34_CR34","first-page":"1096s","volume":"23","author":"J. Thomas","year":"2005","unstructured":"Thomas J, Lipman A, Slatkin N, et al.: A phase III double-blind, placebo-controlled trial of methylnaltrexone (MNTX) for opioid-induced constipation (OIC) in advanced medical illness (AMI). J Clin Oncol 2005, 23(16S):1096s.","journal-title":"J Clin Oncol"},{"key":"34_CR35","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1053\/j.gastro.2006.06.099","volume":"131","author":"N. Slatkin","year":"2006","unstructured":"Slatkin N, Karver S, Thomas J, et al.: A phase III double-blind, placebo-controlled trial of every other day dosing of methylnaltrexone for opioid-induced constipation in advanced illness. Gastroenterology 2006, 131:950.","journal-title":"Gastroenterology"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-007-0034-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-007-0034-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-007-0034-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T20:28:29Z","timestamp":1708115309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-007-0034-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["34"],"URL":"https:\/\/doi.org\/10.1007\/s11912-007-0034-z","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}